Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine

被引：11

作者：

Winokur, Patricia L. ^{[1
,2
]}

Patel, Shital M. ^{[3
,4
]}

Brady, Rebecca ^{[5
]}

Chen, Wilbur H. ^{[6
]}

El-Kamary, Samer S. ^{[6
]}

Edwards, Kathryn ^{[8
]}

Creech, C. Buddy ^{[8
]}

Frey, Sharon

Keitel, Wendy A. ^{[4
]}

Belshe, Robert ^{[9
]}

Walter, Emmanuel ^{[10
]}

Bellamy, Abbie ^{[7
]}

Hill, Heather ^{[7
]}

机构：

[1] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA

[2] Iowa City VA Healthcare Syst, Iowa City, IA USA

[3] Baylor Coll Med, Dept Med, Houston, TX 77030 USA

[4] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA

[5] Cincinnati Childrens Hosp, Gamble Program Clin Studies, Cincinnati, OH USA

[6] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA

[7] EMMES Corp, Rockville, MD USA

[8] Vanderbilt Univ, Dept Pediat, Nashville, TN 37235 USA

[9] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA

[10] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2015年 / 212卷 / 04期

基金：

美国国家卫生研究院;

关键词：

H5N1; influenza; vaccine; prime-boost; MEMORY B-CELLS; PANDEMIC INFLUENZA; ANTIGENIC VARIANT; HUMANS;

D O I：

10.1093/infdis/jiv087

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Influenza A(H5N1) vaccination strategies that improve the speed of the immunological response and cross-clade protection are desired. We compared the immunogenicity of a single 15-mu g or 90-mu g dose of A/H5N1/Indonesia/05/05 (clade 2) vaccine in adults who were previously primed with A/H5N1/Vietnam/1203/2004 (clade 1) vaccine. High-dose vaccine resulted in significantly higher titers to both clade 1 and 2 antigens. Clade 2 titers were unaffected by the previous dose of clade 1 vaccine. Low-dose priming with a mismatched pandemic influenza A(H5N1) vaccine would improve the rapidity, magnitude, and cross-reactivity of the immunological response following a single high-dose, unadjuvanted, pandemic vaccine.

引用

页码：525 / 530

页数：6

共 50 条

[41] Preparing for a possible pandemic: influenza A/H5N1 vaccine development
Keitel, Wendy A.
Atmar, Robert L.
CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (05) : 484 - 490
[42] T-helper cell vaccine for H5N1 influenza
Zinckgraf, John
Powell, Douglas
Wu, Shuzhen
JOURNAL OF IMMUNOLOGY, 2006, 176 : S126 - S126
[43] Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1
Nicolodi, Christina
Groiss, Franz
Kiselev, Oleg
Wolschek, Markus
Seipelt, Joachim
Muster, Thomas
VACCINE, 2019, 37 (28) : 3722 - 3729
[44] Adaptation of Influenza H5N1 Vaccine Viruses in Vero Cells
Tseng, Y. F.
Weng, T. C.
Chen, Y. S.
Hu, A. Y. C.
Chong, P.
Lee, M. S.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E253 - E254
[45] Intraductal infection with H5N1 clade 2.3.4.4b influenza virus
Roubidoux, Ericka Kirkpatrick
Meliopoulos, Victoria
Livingston, Brandi
Brigleb, Pamela H.
Schultz-Cherry, Stacey
JOURNAL OF VIROLOGY, 2025, 99 (03)
[46] Spread of Influenza Virus A (H5N1) Clade 2.3.2.1 to Bulgaria in Common Buzzards
Marinova-Petkova, Atanaska
Georgiev, Georgi
Seiler, Patrick
Darnell, Daniel
Franks, John
Krauss, Scott
Webby, Richard J.
Webster, Robert G.
EMERGING INFECTIOUS DISEASES, 2012, 18 (10) : 1596 - 1602
[47] New Introduction of Clade 2.3.2.1 Avian Influenza Virus (H5N1) into Bangladesh
Islam, M. R.
Haque, M. E.
Giasuddin, M.
Chowdhury, E. H.
Samad, M. A.
Parvin, R.
Nooruzzaman, M.
Rahman, M. M.
Monoura, P.
TRANSBOUNDARY AND EMERGING DISEASES, 2012, 59 (05) : 460 - 463
[48] Avian Influenza (H5N1) Virus of Clade 2.3.2 in Domestic Poultry in India
Nagarajan, Shanmuga
Tosh, Chakradhar
Smith, David K.
Peiris, Joseph Sriyal Malik
Murugkar, Harshad Vinayakrao
Sridevi, Rajangam
Kumar, Manoj
Katare, Megha
Jain, Rajlaxmi
Syed, Zohra
Behera, Padmanava
Cheung, Chung L.
Khandia, Rekha
Tripathi, Sushil
Guan, Yi
Dubey, Shiv Chandra
PLOS ONE, 2012, 7 (02):
[49] Antigenicity and transmissibility of a novel clade 2.3.2.1 avian influenza H5N1 virus
Xu, Lili
Bao, Linlin
Yuan, Jing
Li, Fengdi
Lv, Qi
Deng, Wei
Xu, Yanfeng
Yao, Yanfeng
Yu, Pin
Chen, Honglin
Yuen, Kwok-Yung
Qin, Chuan
JOURNAL OF GENERAL VIROLOGY, 2013, 94 : 2616 - 2626
[50] An MF-59 adjuvanted H5N1 clade 1 pre-pandemic vaccine confers cross-reactive antibodies to a clade 2 H5N1 virus strain
Banzhoff, A.
Gasparini, R.
Laghi-Pasini, F.
Staniscia, T.
Durando, P.
Montomoli, E.
VACCINE, 2008,

← 1 2 3 4 5 →